These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3894715)

  • 21. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of leukemia with cytosine arabinoside--on the intensification of remission].
    Tatsumi N; Masaoka T; Ueda Y; Senda N
    Gan No Rinsho; 1970 Jul; 16(7):706-12. PubMed ID: 5465488
    [No Abstract]   [Full Text] [Related]  

  • 23. [Results in the treatment of acute granulocytic leukemias using a combination of daunorubicine-cytosine arabinoside-cyclophosphamide. Apropos of 35 cases].
    Bauters F; Plouvier B; Caulier MT; Mouton J; Goudemand M
    Lille Med; 1974 Mar; 19(3):226-31. PubMed ID: 4612276
    [No Abstract]   [Full Text] [Related]  

  • 24. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
    Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
    J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of acute myeloblastic leukemia with daunorubicin and cytosine-arabinoside].
    Thorling K; Petersen HS; Jensen KB; Bastrup-Madsen P
    Ugeskr Laeger; 1972 Oct; 134(42):2201-5. PubMed ID: 4507751
    [No Abstract]   [Full Text] [Related]  

  • 26. Our experience with cytosine arabinoside in the treatment of acute haemoblastoses.
    Janele J; Rosa L
    Neoplasma; 1973; 20(4):403-11. PubMed ID: 4517058
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cytosine arabinoside in the treatment of acute leukemia in children].
    Derulska D; Rokicka-Milewska R
    Pediatr Pol; 1975 Jun; 50(6):723-8. PubMed ID: 1169752
    [No Abstract]   [Full Text] [Related]  

  • 28. [Herpesvirus diseases in children with acute leukosis. Treatment with cytosine-arabinoside].
    Gunkel U; Kropp H
    Fortschr Med; 1974 Mar; 92(9):393-5. PubMed ID: 4362176
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of atypical leukemia].
    Mochizuki T; Sawada H; Okazaki T; Tashima M; Uchino H
    Gan To Kagaku Ryoho; 1986 May; 13(5):1816-22. PubMed ID: 3707144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new agent active in the treatment of acute leukemia: cytosine arabinoside].
    Bernard J; Boiron M; Jacquillat C; Weil M; Najean Y
    Presse Med (1893); 1966 Mar; 74(16):799-802. PubMed ID: 5907421
    [No Abstract]   [Full Text] [Related]  

  • 31. [High doses of ARA C in the treatment of acute leukemia].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ; Marín-López A
    Sangre (Barc); 1989 Feb; 34(1):78-9. PubMed ID: 2711290
    [No Abstract]   [Full Text] [Related]  

  • 32. Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study.
    Winkelman MD; Hines JD
    Ann Neurol; 1983 Nov; 14(5):520-7. PubMed ID: 6651239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low dose cytosine arabinoside in the treatment of acute non-lymphoblastic leukemia.
    Insiripong S; Thaisamakr S
    J Med Assoc Thai; 1996 Sep; 79(9):568-71. PubMed ID: 8996985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytosine arabinoside. Results of a cooperative study in acute childhood leukemia.
    Howard JP; Albo V; Newton WA
    Cancer; 1968 Mar; 21(3):341-5. PubMed ID: 5637945
    [No Abstract]   [Full Text] [Related]  

  • 35. [Low-dose cytosine arabinoside (Ara-C) continuous infusion regimen for atypical nonlymphocytic leukemia--clinical study of the remission mechanism by serial chromosomal findings, colony formation and plasma Ara-C concentration].
    Tagawa M; Tomonaga M; Shibata J; Nishino K; Nonaka H; Ikeda S; Suzuyama J; Amenomori T; Matuo T; Kuriyama K
    Rinsho Ketsueki; 1984 Oct; 25(10):1606-17. PubMed ID: 6520937
    [No Abstract]   [Full Text] [Related]  

  • 36. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP; Preisler HD; Slocum H; Rustum YM
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of a clinical study of the preparation Lenvis in leukemias in children and adults].
    Kondrat'eva NA; Kruglova GV; Kovaleva LG; Makhonova LA; Volkova MA
    Probl Gematol Pereliv Krovi; 1981 Dec; 26(12):16-21. PubMed ID: 7036140
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiences with daunomycin and cytosine arabinoside in the therapy of acute myeloid leukemias].
    Kreiter H; Begemann H; Rastetter J
    Med Klin; 1968 Dec; 63(51):2058-66. PubMed ID: 5255517
    [No Abstract]   [Full Text] [Related]  

  • 40. High-dose cytosine arabinoside therapy in acute non-lymphocytic leukemia.
    Preisler HD
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):297-300. PubMed ID: 6538493
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.